The Psychological Experience of Pathological Pregnancy. Study of the Case of Premature Rupture of Membranes and Evaluation of the Impact of Hypnosis Support

NCT05353153 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2025-12-26

No results posted yet for this study

Summary

This research investigates the impact of a hypnosis-based intervention in alleviating state anxiety in Preterm Premature Rupture of Membranes (PPROM). Our main hypothesis is that a two-session intervention can decrease anxiety for pregnant women with PPROM compared to usual care. This research also studies the impact of the experience of a PPROM during a pregnancy on several variables such as perinatal depression, pregnancy-related anxiety, bonding and childbirth experience, as well as control and pain perceived during chilbirth. Our hypotheses are that the experience of PPROM negatively influences these variables, and that this impact is alleviated by the hypnosis-based intervention for the experimental group.

Conditions

  • Preterm Premature Rupture of Membrane

Interventions

OTHER

hypnosis

Hypnosis-based intervention with two sessions of hypnosis (focusing on the treatment of anxiety)

OTHER

standart care

no intervention no hypnosis

Sponsors & Collaborators

  • Laboratory of Psychopathology and Health Processes, University of Paris

    collaborator UNKNOWN
  • University Hospital, Lille

    lead OTHER

Principal Investigators

  • Sara BALAGNY, MD · University Hospital, Lille

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-03
Primary Completion
2025-01-10
Completion
2025-01-10

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05353153 on ClinicalTrials.gov